CervoMed Inc.CRVONASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P44
Within normal range
vs 3Y Ago
0x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -3.48% |
| Q3 2025 | 18.24% |
| Q2 2025 | 5.60% |
| Q1 2025 | -31.73% |
| Q4 2024 | 38.27% |
| Q3 2024 | 35.86% |
| Q2 2024 | 34.05% |
| Q1 2024 | -1.44% |
| Q4 2023 | 59.38% |
| Q3 2023 | -8.52% |
| Q2 2023 | 6.82% |
| Q1 2023 | -3.74% |
| Q4 2022 | 476.16% |
| Q3 2022 | -84.32% |
| Q2 2022 | -13.08% |
| Q1 2022 | 61.24% |
| Q4 2021 | -28.55% |
| Q3 2021 | 6.75% |
| Q2 2021 | -32.36% |
| Q1 2021 | 12.93% |
| Q4 2020 | -17.69% |
| Q3 2020 | 44.38% |
| Q2 2020 | 41.62% |
| Q1 2020 | -7.44% |
| Q4 2019 | -4.91% |
| Q3 2019 | 14.85% |
| Q2 2019 | -10.70% |
| Q1 2019 | 24.53% |
| Q4 2018 | 16.69% |
| Q3 2018 | -15.91% |
| Q2 2018 | -23.82% |
| Q1 2018 | 59.89% |
| Q4 2017 | -35.08% |
| Q3 2017 | 49.07% |
| Q2 2017 | 17.06% |
| Q1 2017 | -31.15% |
| Q4 2016 | -24.60% |
| Q3 2016 | 34.39% |
| Q2 2016 | -38.59% |
| Q1 2016 | 377.32% |